Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • MedEd

    - PMLiVE

    Medscape Education Returns as Thought Leaders to AIS 2025

    📍 September 8–10, 2025 Hilton at Penn’s Landing | Philadelphia, PA Medscape Education is proud to return to the 2025 Alliance Industry Summit (AIS) as a Silver Sponsor and leading...

    Medscape Education

    - PMLiVE

    What Do Pickleball and Medscape Education Have in Common? Heather Lavigne.

    When she’s not taking on challengers on the pickleball court, you can find Heather Lavigne leading Medscape Education’s dynamic insights and impact team as Senior Director. Her leadership philosophy is...

    Medscape Education

    - PMLiVE

    Eli Lilly shares promising phase 3 results for once-weekly insulin candidate efsitora alfa

    The company is planning to submit regulatory applications for the candidate by the end of the year

    regeneron headquarters

    Regeneron gains rights to Hansoh’s GLP-1/GIP receptor agonist in deal worth $2bn

    The candidate is being evaluated in a phase 3 obesity trial and phase 2b diabetes study

    - PMLiVE

    Medscape’s Impact on Women’s Health Education: Key Publications at ISSWSH 2025 & Beyond

    Just in time for Women’s History Month and International Women’s Day on March 8th, Medscape is proud to showcase its dedication to advancing women's health education. Sara Thorpe, MPH, Director,...

    Medscape Education

    - PMLiVE

    Amplifying Women’s Voices in Healthcare: Medscape Education’s Award-Winning Podcast Series

    “Be the change you want to see in the world.” Though the origins of this quote are a little fuzzy, the idea is crystal clear, and can inspire you to...

    Medscape Education

    - PMLiVE

    Impactful Advances in Aesthetic Medicine

    Medscape is pleased to announce new advancements within its Clinical Advances in Aesthetic Medicine. Launched in 2022, this initiative has effectively educated MD practitioners, showcasing measurable outcomes with submissions to...

    Medscape Education

    - PMLiVE

    Eli Lilly announces $3bn expansion to US injectables manufacturing facility

    The investment will help Lilly meeting the growing demand for its diabetes and obesity medicines

    - PMLiVE

    Sanofi unveils plans to build €1bn insulin production base in China

    The site will focus on serving the insulin medication needs of local diabetic patients

    - PMLiVE

    Advancing Education at AASLD 2024

    Get ready for an exciting experience at AASLD 2024! The Medscape team is thrilled to be in San Diego from November 15-19 for this year’s AASLD conference, where we will...

    Medscape Education

    - PMLiVE

    Successful Education at ESC

    With World Heart Day just having passed (29th September), Medscape wants to take the opportunity to look back and recap what was accomplished at ESC 2024.  At this year’s event,...

    Medscape Education

    - PMLiVE

    Common antidiabetic drug metformin found to slow growth of precancerous cells

    The findings suggest that the drug could be used to manage squamous oesophageal cancer risk

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links